Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission
J. Brooks Jackson(VA Tennessee Valley Healthcare System), Susan H. Eshleman(Johns Hopkins University), Philippa Musoke(Centers for Disease Control and Prevention), Martin Mracna(United States Department of Health and Human Services), Graziella Becker‐Pergola(Government of the United States of America), Francis Mmiro(Makerere University), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Mary Glenn Fowler(Johns Hopkins University), Laura Guay(Johns Hopkins University), Mark Mirochnick(Government of the United States of America)
Cited by 213
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896